Valganciclovir hydrochloride

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

D-Valganciclovir-d5 Hydrochloride.

K252c is a cell-permeable PKC inhibitor (IC₅₀s = 2.45 and 25.

ST-193 hydrochloride is a potent broad-spectrum arenavirus inhibitor: inhibits Guanarito, Junin, Lassa and Machupo virus with IC 50 values of 0.44, 0.62, 1.4 and 3.1 nM, respectively.In VitroST-193 inhibits LASV pseudotypes with an IC 50 of 1.6 nM.

ST-193 hydrochloride is a potent broad-spectrum arenavirus inhibitor: inhibits Guanarito, Junin, Lassa and Machupo virus with IC 50 values of 0.44, 0.62, 1.4 and 3.1 nM, respectively.In VitroST-193 inhibits LASV pseudotypes with an IC 50 of 1.6 nM.

ST-193 hydrochloride is a potent broad-spectrum arenavirus inhibitor: inhibits Guanarito, Junin, Lassa and Machupo virus with IC 50 values of 0.44, 0.62, 1.4 and 3.1 nM, respectively.In VitroST-193 inhibits LASV pseudotypes with an IC 50 of 1.6 nM.

ST-193 hydrochloride is a potent broad-spectrum arenavirus inhibitor: inhibits Guanarito, Junin, Lassa and Machupo virus with IC 50 values of 0.44, 0.62, 1.4 and 3.1 nM, respectively.In VitroST-193 inhibits LASV pseudotypes with an IC 50 of 1.6 nM.

ST-193 hydrochloride is a potent broad-spectrum arenavirus inhibitor: inhibits Guanarito, Junin, Lassa and Machupo virus with IC 50 values of 0.44, 0.62, 1.4 and 3.1 nM, respectively.In VitroST-193 inhibits LASV pseudotypes with an IC 50 of 1.6 nM.

ST-193 hydrochloride is a potent broad-spectrum arenavirus inhibitor: inhibits Guanarito, Junin, Lassa and Machupo virus with IC 50 values of 0.44, 0.62, 1.4 and 3.1 nM, respectively.In VitroST-193 inhibits LASV pseudotypes with an IC 50 of 1.6 nM.

The orally bioavailable, valyl ester prodrug of ganciclovir, an antiviral agent that inhibits viral DNA synthesis (IC₅₀ = 0.95 &muM) by targeting the CMV polymerase used for the treatment of HIV associated retinitis and for the

The orally bioavailable, valyl ester prodrug of ganciclovir, an antiviral agent that inhibits viral DNA synthesis (IC₅₀ = 0.95 &muM) by targeting the CMV polymerase used for the treatment of HIV associated retinitis and for the

The orally bioavailable, valyl ester prodrug of ganciclovir, an antiviral agent that inhibits viral DNA synthesis (IC₅₀ = 0.95 &muM) by targeting the CMV polymerase used for the treatment of HIV associated retinitis and for the